ask="3.60"
ask_size="1300"
average_daily_volume="336168"
bid="3.38"
bid_size="100"
book_value="0.34"
change="+2.06"
change_from_200_day_moving_average="2.03"
change_from_50_day_moving_average="2.09"
change_from_52_week_high="-1.40"
change_From_52_week_low="2.59"
change_in_percent="+125.62%"
close="3.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="4192000"
high="3.90"
high_52_weeks="5.10"
last_trade_date="2/21/2017"
last_trade_price="3.70"
last_trade_size="4096"
last_trade_time="4:00pm"
low="2.13"
low_52_weeks="1.11"
market_capitalization="35.46M"
moving_average_200_day="1.67"
moving_average_50_day="1.61"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="2.46"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+121.95%"
percent_change_from_50_day_moving_average="+129.42%"
percent_change_from_52_week_high="-27.45%"
percent_change_from_52_week_low="+233.33%"
previous_close="1.64"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.84"
price_per_sales="30.89"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.76"
stock_exchange="NCM"
symbol="EYEG"
volume="29776026"
weeks_range_52="1.11 - 5.10"
